Novo Nordisk CEO Mike Doustdar told Jim Cramer about developments in obesity treatment.
Source: CNBC
Tuesday, 13. January 2026
Share:
13. January 2026 00:29
Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs
